The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New leadership moves, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Leadership Trends
See who's moving and how much in your market
No credit card required Weekly executive digest
Immuno Genesis Appoints Claudio Dansky Ullmann As Chief Medical Officer
PRIVATEMay 28, 2026•19 days ago
Position
Chief Medical Officer
Company
ImmunoGenesis
Claudio Dansky Ullmann
HoustonBiotechnology
Description
ImmunoGenesis has announced the appointment of Claudio Dansky Ullmann, M.D. as Chief Medical Officer. Dr
Company Information
Company
ImmunoGenesis
Location
2450 Holcombe Blvd, Suite J
Houston, Texas, United States
About
ImmunoGenesis is a clinical-stage immuno-oncology biopharmaceutical company re-envisioning the treatment of "cold" tumors, particularly of immune-excluded tumors. Immune-excluded tumors, which account for more than half of all cancers, are characterized by having mechanisms of resistance that suppress the immune response; this subgroup is resistant to current immunotherapies. ImmunoGenesis is creating therapies based on the pathology of these immune-excluded tumors that are rationally designed to overcome immune exclusion and thereby drive an effective immune response.
HoustonBiotechnology